Knowledge Networks buys pharmaceutical researcher CMR
Share
US— Knowledge Networks has acquired pharmaceutical and biotech research agency CMR for an undisclosed amount.
CMR (Caduceus Marketing Research) operates a 70,000-strong panel of US physicians and healthcare professionals from the primary care sector. It offers full-service research to clients in the pharmaceutical sector and offers direct access to its panel to other analyst firms.
Simon Kooyman (pictured), Knowledge Networks’ CEO, said: “CMR’s assets, people and client focus are extremely compatible with KN’s. The ability to understand physician practices and attitudes - especially difficult in specialities like oncology - has become imperative for pharma marketers.”
Knowledge Networks will use CMR’s panel to conduct more extensive custom research in areas such as the use of drugs for oncology regimes and other speciality products.
Jim Vielee, head of CMR, said: “Knowledge Networks will bring bring a host of benefits to our clients, broadening our offerings and giving us a stronger foundation to support CMR’s business with both manufacturers and researchers.”
